AD

Abhinav D.

Chief Executive Officer at Sphaera Pharma

Abhinav D. has a diverse work experience spanning multiple roles and industries. Abhinav started their career as a Business Development Intern at SAI Life Sciences Ltd in 2007. Abhinav then moved on to Sphaera Pharma, where they worked as the Manager of Corporate Affairs & Finance from 2008 to 2012, and later as the VP of Corporate Affairs from 2012 to 2019. During their time at Sphaera Pharma, Abhinav focused on business planning and development, global growth management, and strategy execution. Abhinav also gained experience in managing site operations, business development, and business strategy.

In 2014, Abhinav joined Cyro Healthcare Pvt. Ltd as a Director, where they played a significant role in setting up cGMP operations for a medical device manufacturing company. Abhinav also expanded the company's product line to include home healthcare devices and served as a contract manufacturer for other brands.

Abhinav's most recent position is as the Chief Business Officer at Myto Therapeutics, a biotech company that develops small-molecule drugs for orphan mitochondrial diseases. Abhinav oversees the development and commercialization of their patented prodrug technology.

Overall, Abhinav D. has demonstrated expertise in strategic planning, team leadership, and business development across the pharmaceutical and biotech industries.

Abhinav D. completed their Master of Business Administration (MBA) degree in Finance & Marketing from IILM between 2006 and 2008. Prior to that, they obtained a Bachelor of Commerce (B.Com.) degree in Accounting and Finance from Bhavans College from 2002 to 2005. Abhinav also attended DC Business School Indore for Class 12th from 2000 to 2002. Abhinav completed their primary and secondary education at Gyan Bharati School in India from 1990 to 2000.

Links

Previous companies

SAI Life Sciences logo

Timeline

  • Chief Executive Officer

    November, 2019 - present

  • VP - Corporate Affairs

    April, 2012

  • Manager - Corporate Affairs & Finance

    January, 2008